Xeris Biopharma Holdings (XERS) Earnings Date & Reports

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

XERS is expected to report earnings to fall 48.67% to -3 cents per share on August 06

Xeris Biopharma Holdings XERS Stock Earnings Reports

Q2'25

Est.

$-0.03

Q1'25

Missed

by $0.01

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.02

Q2'24

Est.

$-0.10

The last earnings report on May 08 showed earnings per share of -5 cents, missing the estimate of -5 cents. With 1.59M shares outstanding, the current market capitalization sits at 784.76M.

View a ticker or compare two or three

Compare

XERS